Patent · US Active

Determining tumor origin

US9670553B2 · kind B2 · utility

2Cited by
1References
15Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 27, 2015
Grant dateJun 6, 2017
Priority date
Expiry dateJul 27, 2035

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12Q2600/16
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The disclosure provides methods for the use of gene expression measurements to classify or identify among 54 cancer types in samples obtained from a subject in a clinical setting, such as in cases of formalin fixed, paraffin embedded (FFPE) samples.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.